271 related articles for article (PubMed ID: 36030499)
1. IL-34 deficiency impairs FOXP3
Freuchet A; Salama A; Bézie S; Tesson L; Rémy S; Humeau R; Règue H; Sérazin C; Flippe L; Peterson P; Vimond N; Usal C; Ménoret S; Heslan JM; Duteille F; Blanchard F; Giral M; Colonna M; Anegon I; Guillonneau C
Clin Transl Med; 2022 Aug; 12(8):e988. PubMed ID: 36030499
[TBL] [Abstract][Full Text] [Related]
2. IL-34 Actions on FOXP3
Bézie S; Freuchet A; Sérazin C; Salama A; Vimond N; Anegon I; Guillonneau C
Front Immunol; 2020; 11():1496. PubMed ID: 32849510
[TBL] [Abstract][Full Text] [Related]
3. IL-34 is a Treg-specific cytokine and mediates transplant tolerance.
Bézie S; Picarda E; Ossart J; Tesson L; Usal C; Renaudin K; Anegon I; Guillonneau C
J Clin Invest; 2015 Oct; 125(10):3952-64. PubMed ID: 26389674
[TBL] [Abstract][Full Text] [Related]
4. An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.
Do JS; Visperas A; Sanogo YO; Bechtel JJ; Dvorina N; Kim S; Jang E; Stohlman SA; Shen B; Fairchild RL; Baldwin WM; Vignali DA; Min B
Mucosal Immunol; 2016 Jan; 9(1):137-45. PubMed ID: 26013006
[TBL] [Abstract][Full Text] [Related]
5. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
6. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.
Abe Y; Urakami H; Ostanin D; Zibari G; Hayashida T; Kitagawa Y; Grisham MB
PLoS One; 2009 Nov; 4(11):e7840. PubMed ID: 19956764
[TBL] [Abstract][Full Text] [Related]
7. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.
Beres AJ; Haribhai D; Chadwick AC; Gonyo PJ; Williams CB; Drobyski WR
J Immunol; 2012 Jul; 189(1):464-74. PubMed ID: 22649199
[TBL] [Abstract][Full Text] [Related]
8. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.
Belle L; Agle K; Zhou V; Yin-Yuan C; Komorowski R; Eastwood D; Logan B; Sun J; Ghilardi N; Cua D; Williams CB; Gaignage M; Marillier R; van Snick J; Drobyski WR
Blood; 2016 Oct; 128(16):2068-2082. PubMed ID: 27488350
[TBL] [Abstract][Full Text] [Related]
9. IL-25 promotes the function of CD4+CD25+ T regulatory cells and prolongs skin-graft survival in murine models.
Tang J; Zhou X; Liu J; Meng Q; Han Y; Wang Z; Fan H; Liu Z
Int Immunopharmacol; 2015 Oct; 28(2):931-7. PubMed ID: 25864622
[TBL] [Abstract][Full Text] [Related]
10. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
Front Immunol; 2021; 12():637630. PubMed ID: 33717186
[No Abstract] [Full Text] [Related]
12. Human LAP
Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
14. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
[TBL] [Abstract][Full Text] [Related]
16. Very Low Numbers of CD4
Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
[TBL] [Abstract][Full Text] [Related]
17. Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice.
Lee SE; Li X; Kim JC; Lee J; González-Navajas JM; Hong SH; Park IK; Rhee JH; Raz E
Gastroenterology; 2012 Jul; 143(1):145-54. PubMed ID: 22475534
[TBL] [Abstract][Full Text] [Related]
18. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
[TBL] [Abstract][Full Text] [Related]
19. HSF1 promotes CD69
Yu L; Zhou B; Zhu Y; Li L; Zhong Y; Zhu L; Wang H; Chen H; Xu J; Guo T; Feng L; Wang X; Cai Z; Wang J; Jin H
Theranostics; 2023; 13(6):1892-1905. PubMed ID: 37064870
[TBL] [Abstract][Full Text] [Related]
20.
Bézie S; Meistermann D; Boucault L; Kilens S; Zoppi J; Autrusseau E; Donnart A; Nerrière-Daguin V; Bellier-Waast F; Charpentier E; Duteille F; David L; Anegon I; Guillonneau C
Front Immunol; 2017; 8():2014. PubMed ID: 29445370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
